Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction.
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis Patients
Clinically isolated syndromes.
AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Understanding the Role of T Cells in CNS Homeostasis.
Glatiramer acetate induced hepatotoxicity.
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Pages
« first
‹ previous
…
38
39
40
41
42
43
44
45
46
…
next ›
last »